Latest Commercialisation News

Dimerix has received a US$10 million upfront payment from Everest Medicines under a regional licensing deal for DMX-200 targeting FSGS in Greater China, South Korea and Southeast Asia. This deal marks Dimerix’s fifth commercial partnership for DMX-200, collectively worth up to A$1.9 billion in milestones and royalties.

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.

Ridley Corporation’s FY26 results reveal a dramatic revenue surge fueled by its Incitec Pivot Fertilisers acquisition, alongside a significant profit drop due to a $31.8 million impairment on NovaqPro® and acquisition costs. The company declares a higher fully franked dividend, signaling confidence despite challenges.

Mount Ridley Mines has lodged a provisional patent for its SelectroTM hydrometallurgical leach technology, demonstrating superior recoveries of rare earths, scandium, and gallium compared to conventional methods. The company is advancing testwork and commercial discussions to capitalise on the innovation.

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.

Kinetiko Energy’s South African subsidiary has locked in a $1.26 million cash agreement with Mulilo, resolving land-use conflicts and gaining a potential gas supply edge for a major wind energy project.

Environmental Clean Technologies has secured A$10.6 million in a placement to fast-track commercialisation of its Flash Joule Heating platform and MXene manufacturing, backed by a strategic acquisition and feedstock supply.

ION Video has appointed two seasoned executives to its board and elevated Anthony Baker to Managing Director as it sharpens focus on scaling its patented video technology. Founder Finbar O’Hanlon steps back from the board to concentrate on innovation and expanding the company’s IP portfolio.

Hansen Technologies posted a modest 1.5% revenue dip to $386.5 million in FY26 but delivered a 15.9% rise in underlying NPATA to $65.9 million, driven by recurring revenue growth and AI-enabled efficiencies. The company also announced a planned CEO succession to support its next growth phase.

Entropy Neurodynamics has partnered with BioCina to establish GMP manufacturing for its intravenous psilocin formulation TRP-8803, a critical step toward late-stage clinical trials and commercialisation.

Buru Energy has boosted its Ungani oil field’s 2C Contingent Resources by around 200%, lifting recoverable oil estimates to 660,000 barrels while exploring new, lower-cost production and local refining options.

The Environmental Group Limited (ASX:EGL) posted flat revenue of $112 million for FY26 but saw a sharp 44.7% fall in EBITDA and a $6 million net loss, weighed down by operational disruptions, a major ERP system implementation, and a $3 million goodwill impairment.